Form 4: AIM ImmunoTech Director Sells Shares Received as Compensation
SEC Form 4 Filing
William M. Mitchell, a director at AIM ImmunoTech Inc., disposed of shares acquired as compensation under the company's Cash Conservation Plan.
Summary
- On January 31, 2025, William M. Mitchell, a director of AIM ImmunoTech Inc., disposed of 25,797 shares of common stock.
- The shares were sold at a price of $0.2019 per share.
- These shares were issued in lieu of director compensation under the company's Cash Conservation Plan.
- Following the transaction, Mitchell directly owns 198,063 shares.
- Mitchell also indirectly owns 190 shares through a spouse and 190 shares through trusts.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for directors to receive stock as part of their compensation and subsequently sell those shares.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the amount is relatively small.
Key Dates
| Date | Description |
|---|---|
| 01/31/2025 | Date of transaction: Director disposed of shares. |
| 02/03/2025 | Date of signature on the Form 4 filing. |
Keywords
AIM ImmunoTech, Director, Share Disposal, Form 4, Mitchell, Compensation, Cash Conservation Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.